Peraza Lisa
SEC CIK 1828266 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | VP, CAO | 55.4K | — | — | 23 | 2021-04-30 | 2024-01-13 |
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Peraza Lisa made no open-market trades at HRTX in the last 12 months.
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-16 | 2024-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +1,841 | 55.4K | +3% | — |
| D | 2024-01-16 | 2024-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $2.15 | -756 | 55.9K | -1% | -$1,625 |
| DM | 2023-10-17 | 2023-07-25+ | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $1.47 | -15.6K | 53.2K | -23% | -$22.9K |
| DM | 2023-10-17 | 2023-07-25+ | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +45.1K | 55.7K | +427% | — |
| D | 2023-07-17 | 2023-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $1.31 | -860 | 25.3K | -3% | -$1,127 |
| DM | 2023-07-17 | 2023-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +2,485 | 26.2K | +10% | — |
| D | 2023-04-17 | 2023-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $2.88 | -860 | 23.7K | -4% | -$2,477 |
| DM | 2023-04-17 | 2023-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +2,484 | 22.6K | +12% | — |
| D | 2023-01-17 | 2023-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $3.17 | -1,013 | 22.1K | -4% | -$3,211 |
| DM | 2023-01-17 | 2023-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +2,485 | 21.1K | +13% | — |
| D | 2022-10-17 | 2022-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $3.76 | -861 | 20.6K | -4% | -$3,237 |
| DM | 2022-10-17 | 2022-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +2,485 | 21.4K | +13% | — |
| DM | 2022-07-15 | 2022-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +2,485 | 19.8K | +14% | — |
| D | 2022-07-15 | 2022-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $3.01 | -860 | 19.0K | -4% | -$2,589 |
| DM | 2022-04-15 | 2022-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +2,484 | 18.2K | +16% | — |
| D | 2022-04-15 | 2022-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $6.07 | -860 | 17.3K | -5% | -$5,220 |
| DM | 2022-01-14 | 2022-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +2,485 | 14.7K | +20% | — |
| D | 2022-01-14 | 2022-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $8.30 | -966 | 15.7K | -6% | -$8,018 |
| D | 2021-10-15 | 2021-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $10.55 | -191 | 14.2K | -1% | -$2,015 |
| D | 2021-10-15 | 2021-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +552 | 14.4K | +4% | — |
| D | 2021-07-15 | 2021-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | J - Other | $13.90 | +1,530 | 13.5K | +13% | +$21.3K |
| D | 2021-07-15 | 2021-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | F - Tax | $13.48 | -191 | 13.8K | -1% | -$2,575 |
| D | 2021-07-15 | 2021-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Peraza Lisa | VP, CAO | M - OptEx | — | +552 | 14.0K | +4% | — |
Purchase Sale Sale after option exercise All abbreviations